F18.25

Clinical Causes: Prolonged exposure to inhalant chemicals such as solvents, aerosols, or nitrites. Genetic predisposition to substance dependence or mental health disorders. Psychological factors, including stress, trauma or peer influence. Environmental factors, such as availability and peer pressure. Early initiation of inhalant use during adolescence. Concurrent use of other substances that may increase the risk of dependence and psychosis.

Key Symptoms: Craving or persistent desire to use inhalants. Inability to control or reduce inhalant consumption despite adverse effects. Physical symptoms such as dizziness, headaches, nausea, or muscle weakness. Altered mental state, including confusion, hallucinations, or paranoid thinking. Psychotic episodes characterized by delusions or hallucinations that are closely linked to inhalant use. Behavioral changes, including social withdrawal, neglect of responsibilities, and risky behaviors. Development of tolerance, needing larger amounts of inhalants to achieve the same effect. Withdrawal symptoms upon cessation, such as tremors, irritability, or mood disturbances.

Diagnosis Path: Diagnosis of inhalant dependence with inhalant-induced psychotic disorder involves medical and psychological evaluations, including detailed substance use history and mental health assessments. Clinicians may utilize DSM-5 criteria for substance use disorder and identify psychotic symptoms in relation to inhalant use. Laboratory tests and toxicology screening can assist in confirming recent inhalant exposure. Mental health specialists may employ interviews and questionnaires to evaluate the severity and impact of symptoms, along with physical examinations to rule out other causes of psychosis.

Treatment Protocols: Treatment strategies focus on both detoxification from inhalants and management of psychotic symptoms. Approaches may include: - Detoxification programs to safely manage withdrawal symptoms. - Psychotherapy, such as cognitive-behavioral therapy (CBT), to address dependence and underlying psychological issues. - Medications to manage psychosis, such as antipsychotics, under psychiatric supervision. - Support groups and counseling to provide social support and prevent relapse. - Addressing co-occurring mental health or substance use disorders for comprehensive care. Effective treatment requires an integrated approach tailored to individual needs, often involving multidisciplinary teams including psychiatrists, psychologists, and addiction specialists.